From AIDS to SARS to Covid, Dr. Julie Gerberding has helped manage decades of public health crises, as a physician, director of the CDC and now Merck's Chief Patient Officer.
One common thread -- and one she is determined to overcome -- is inequities in access to information, medicines and treatments.
In this Vanguard Network dialogue, Dr. Gerberding shares her vision for improving access and efficacy in spite of the ripple effect of the pandemic.
